INGLIS DANIEL J,LAVRANOS TINA C.,KREMMIDIOTIS GABRIEL
申请号：
NZ63046513
公开号：
NZ630465A
申请日:
2013.06.03
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
Disclosed is the use of: (a) a vascular disrupting agent (VDA) and (b) at least one hypoxia targeting agent, in the manufacture of a medicament for the treatment of a proliferative disease wherein the hypoxia targeting agent is Pazopanib or Bortezomib and the VDA is a compound of formula (Ib) or a salt, solvate or prodrug thereof.
